---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-088499"
form_type: "8-K"
ticker: "BCAB"
cik: "0001826892"
company_name: "BioAtla, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:44:08.001772+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# BioAtla sets 2025 bonus targets, elects directors at annual meeting

## Summary
- 2025 Bonus Plan approved: CEO target 60% of base, CFO 40%, CMO 40%; payout 50%-125%.
- Corporate goals: clinical milestones 25%, financing 50%, financial/people 20%, brand awareness 5%.
- Annual meeting elected directors Gray, Moran, Steinman; ratified Ernst & Young as auditor (30.2M for).
- Say-on-pay non-binding vote passed with 8.96M for vs 4.49M against; 52% of shares voted.

## SEC filing metadata
- accession: 0000950170-25-088499
- form_type: 8-K
- ticker: BCAB
- cik: 0001826892
- company_name: BioAtla, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826892/000095017025088499/0000950170-25-088499-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826892/000095017025088499/bcab-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-088499
- JSON: https://secwatch.observer/filing/0000950170-25-088499.json
- Plain text: https://secwatch.observer/filing/0000950170-25-088499.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.